Document is current
Any future updates will be listed below
-
Authors
Welsh, Robert C. https://orcid.org/0000-0003-2613-9142
Dehghani, Payam
Lopes, Renato
Wojdyla, Daniel M
Aronson, Ronald
Granger, Christopher B
Windecker, Stephan
Vora, Amit N
Vinereanu, Dragos
Halvorsen, Sigrun
Parkhomenko, Alexander
Mehran, Roxana
Alexander, John H
Goodman, Shaun
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02415400 at ClinicalTrials.govDocuments that mention this clinical trial
Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention
https://doi.org/10.1161/circulationaha.120.051020
Relative Benefit of Dual Versus Single Antiplatelet Therapy Among Patients With Atrial Fibrillation on Oral Anticoagulation According to Time After ACS and PCI: Insights From the AUGUSTUS Trial
https://doi.org/10.1161/circinterventions.123.013596
Bleeding associated with the management of acute coronary syndromes
https://doi.org/10.1136/heartjnl-2015-307602
Impact of prior oral anticoagulant use and outcomes on patients from secondary analysis in the AUGUSTUS trial
https://doi.org/10.1136/openhrt-2021-001892
-
Funding
Funding for this research was provided by:
Pfizer
Bristol-Myers Squibb
- License Information
